Current Opinion in Psychiatry was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Lynn E. DeLisi
Lynn E. DeLisi, MD, is currently Attending Psychiatrist at the VA Boston Healthcare System and Professor of Psychiatry, Harvard Medical School, Boston, USA. In addition, she is Editor-in-Chief of the journal Psychiatry Research, Co-founding editor of Schizophrenia Research, Co-Founder and president of the Schizophrenia International Research Society (SIRS), Co-Founder, former secretary of the International Society of Psychiatric Genetics (ISPG) and a fellow of the American College of Neuropsychopharmacology (ACNP) and the American Association for the Advancement of Science (AAAS). In October 2007 and in 2013 she chaired or co-chaired the World Congress of Psychiatric Genetics in NYC and Boston for over 1000 participants and for several years has been an organizer of the Schizophrenia International Research Society Conference taking place in Italy and beginning this year (2019) in the USA as well.
Her undergraduate degree is in zoology from The University of Wisconsin, USA. She obtained her MD degree from the Medical College of Pennsylvania, USA, and went on from there to do three years of general practice work with the migrant Chile farmers of Northern New Mexico. She completed a residency in psychiatry at Saint Elizabeth's Hospital, Washington, DC, USA, and was a post-doctoral fellow and then a full-time staff research psychiatrist in the NIMH intramural research program, St. Elizabeth's Hospital (Washington, DC, USA) and the NIH Campus (Bethesda, Maryland, USA). In 1987, she moved to The State University of New York, USA, at Stony Brook where she set up several research programs on the longitudinal biological outcome of schizophrenia, emphasizing both brain imaging and genetic studies. From 2001 through 2008 she was Professor of Psychiatry at New York University School of Medicine, USA, and Associate Director of The Center for Advanced Brain Imaging at The Nathan S. Kline Institute for Psychiatric Research, until she obtained her current position in Boston. Here, she has dedicated her career to research programs on detection of schizophrenia, while at the same time treating chronic patients with schizophrenia, specifically those who are Veterans of the USA Armed Forces and have had mental illness sometimes suffered as a consequence of the trauma they experienced in active combat. She also teaches and mentors several residents and trainees, both locally and internationally at congresses. She has edited and authored over 300 books and manuscripts and serves on the editorial board of several other journals. In her off hours, she volunteers as the Vice-Chair of her local town's Planning Board and works on issues, such as the legalization of marijuana that affects her local neighbors in many ways.
Iris E.C. Sommer
Iris E.C. Sommer studied medicine in Amsterdam and public health in Maastricht. She obtained her PhD cum laude at University Utrecht, The Netherlands, in 2004 on brain imaging in schizophrenia. In 2011, Sommer was appointed Professor of Psychiatry at the University Medical Centre Utrecht, The Netherlands, where she initiated the Voices Clinic. Currently, she is professor of cognitive aspects of neurological and psychiatric disorders at the department of neuroscience in UMCG, The Netherlands. Since 2016, she is visiting professor at the Norwegian Center of Excellence, University of Bergen, Norway, in the department of medical and biological psychology. She received a Veni, Clinical Fellowship, Vidi and TOP grant from ZonMW, and recently a large grant to study the effects of antipsychotic maintenance treatment in early psychosis.
Professor Sommer was elected as a member of the Young Academy of the KNAW (Royal Dutch Academy of Sciences) and is a member of the Permanent Committee for Large Research Infrastructure at NWO. She is consultant to GABATHER, a small company developing new GABAergic treatment for psychiatric disorders, and a member of the Dutch Committee for Research Integrity (LOWI). She is associate editor of Schizophrenia Bulletin, Psychological Medicine and The Dutch Medical Journal (NTVG).
She has published two popular science books. The most recent, Haperende Hersenen, became a national bestseller. Sommer has published over 250 articles on hallucinations, language, cognition and psychosis. Her current research interest is related to the association between cognitive dysfunction and activity of the immune system. Her aim is to develop new treatment to support people with cognition deficits during their recovery of medical, psychiatric or neurological disorders.
Christopher P. Szabo
Christopher P. Szabo is Professor and Academic Head, Department of Psychiatry, Faculty of Health Sciences, University of the Witwatersrand, South Africa, and Head of Clinical Department – Psychiatry at the Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa. He is the former Editor-in-Chief of the African Journal of Psychiatry and current Editor-in-Chief of South African Psychiatrywww.southafricanpsychiatry.co.za.